Precipio launches its much-anticipated quantitative bcr-abl 2.0 panel

New haven, conn., aug. 08, 2023 (globe newswire) -- specialty cancer diagnostics company precipio, inc. (nasdaq: prpo) , announces the launch of its new quantitative bcr-abl 2.0 panel, with features making it the most innovative panel of its kind on the market.
PRPO Ratings Summary
PRPO Quant Ranking